New England Journal of Medicine· 2018Q1· Review
Immune-Related Adverse Events Associated with Immune Checkpoint Blockade
- 4,738citations
- Q1SCImago
- 2018year
Short summary
Immune checkpoint blockade (ICB) therapy, while effective for cancer, causes a wide range of immune-related adverse events (irAEs) that can complicate treatment.
AI-generated from the title and abstract; the full text is not read.
TakeawaysIn the app
Key pointsIn the app
Ask the paperIn the app
The rest is in the Pofolia app
Takeaways, key points and questions to the paper; new summaries every day for your field. Free.
Sign in on the web to openField: Oncology
OncologyMedicine